Chronic kidney disease

Surgery

Volumn 28, Issue 11, 2010, Pages 525-529

  Haynes, Richard J ^a   Winearls, Christopher G ^a  

^a CHURCHILL HOSPITAL   (United Kingdom)

Author keywords

Anaemia; blood pressure; chronic kidney disease; end stage renal disease; glomerular filtration rate; proteinuria

Indexed keywords

ALEMTUZUMAB; ANGIOTENSIN RECEPTOR ANTAGONIST; ANTILIPEMIC AGENT; AZATHIOPRINE; BASILIXIMAB; BICARBONATE; CALCINEURIN INHIBITOR; CYCLOSPORIN A; DACLIZUMAB; DESMOPRESSIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; EVEROLIMUS; GENTAMICIN; MYCOPHENOLIC ACID; NONSTEROID ANTIINFLAMMATORY AGENT; PREDNISOLONE; RAPAMYCIN; TACROLIMUS; TESTOSTERONE; THYMOCYTE ANTIBODY;

ACNE; AMYLOIDOSIS; ANALGESIC NEPHROPATHY; ANEMIA; ANTIHYPERTENSIVE THERAPY; BACTERIAL INFECTION; BLOOD CLOTTING DISORDER; BLOOD PRESSURE MEASUREMENT; CARDIOVASCULAR DISEASE; CHRONIC KIDNEY DISEASE; CONTRAST INDUCED NEPHROPATHY; DIABETIC NEPHROPATHY; DIARRHEA; DYSMENORRHEA; ERECTILE DYSFUNCTION; FOCAL GLOMERULOSCLEROSIS; GLUCOSE INTOLERANCE; HEMODIALYSIS; HEMOLYTIC UREMIC SYNDROME; HUMAN; HYPERKALEMIA; HYPERLIPIDEMIA; HYPERPLASIA; HYPERPROLACTINEMIA; HYPERTENSION; HYPOXIA; IMMUNOGLOBULIN A NEPHROPATHY; IMMUNOSUPPRESSIVE TREATMENT; KIDNEY EXAMINATION; KIDNEY FAILURE; KIDNEY POLYCYSTIC DISEASE; KIDNEY SIZE; KIDNEY TRANSPLANTATION; LEUKOPENIA; LUNG INJURY; LYMPHOCELE; LYMPHOCYTOPENIA; LYMPHOMA; MEGALOCYTOSIS; MEMBRANOUS GLOMERULONEPHRITIS; MORTALITY; MYELODYSPLASTIC SYNDROME; MYELOMA; NEPHROTOXICITY; NEUROPATHY; OPHTHALMOSCOPY; OSTEOPOROSIS; PERITONEAL DIALYSIS; POSTOPERATIVE COMPLICATION; PRIORITY JOURNAL; PROSTATE DISEASE; PROTEINURIA; RASH; REFLUX NEPHROPATHY; RENAL REPLACEMENT THERAPY; RESPIRATION DEPRESSION; RETROPERITONEAL FIBROSIS; SECONDARY HYPERPARATHYROIDISM; SEXUAL DYSFUNCTION; SHORT SURVEY; SUBFERTILITY; TESTOSTERONE BLOOD LEVEL; TREMOR; ULTRASOUND; URINALYSIS; VASCULITIS; WATER INTOXICATION; WOUND HEALING IMPAIRMENT;

EID: 78049269574     PISSN: 02639319     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.mpsur.2010.08.003     Document Type: Review

References (9)

1. A.S. Levey, K.U. Eckardt, and Y. Tsukamoto Definition and classification of chronic kidney disease: a position statement from Kidney Disease: Improving Global Outcomes (KDIGO) Kidney Int 67 6 2005 Jun 2089 2100
2. M. Rutkowski, W. Mann, and S. Derose Implementing KDOQI CKD Definition and Staging Guidelines in Southern California Kaiser Permanente Am J Kidney Dis 53 3, suppl 3 2009 S86 S99
3. C. Ponticelli, P. Zucchelli, P. Passerini, B. Cesana, and The Italian Idiopathic Membranous Nephropathy Treatment Study Group Methylprednisolone plus chlorambucil as compared with methylprednisolone alone for the treatment of idiopathic membranous nephropathy N Engl J Med 327 9 1992 Aug 27 599 603
4. The Diabetes Control and Complications (DCCT) Research Group Effect of intensive therapy on the development and progression of diabetic nephropathy in the Diabetes Control and Complications Trial Kidney Int 47 6 1995 Jun 1703 1720
5. S. Klahr, A.S. Levey, and G.J. Beck The effects of dietary protein restriction and blood-pressure control on the progression of chronic renal disease. Modification of Diet in Renal Disease Study Group N Engl J Med 330 13 1994 Mar 31 877 884
6. T.H. Jafar, C.H. Schmid, and M. Landa Angiotensin-converting enzyme inhibitors and progression of nondiabetic renal disease. A meta-analysis of patient-level data Ann Intern Med 135 2 2001 Jul 17 73 87
7. C. Wanner, V. Krane, and W. Marz Atorvastatin in patients with type 2 diabetes mellitus undergoing hemodialysis N Engl J Med 353 3 July 21, 2005 238 248 (Pubitemid 41058323)
8. B.C. Fellstrom, A.G. Jardine, and R.E. Schmieder Rosuvastatin and cardiovascular events in patients undergoing hemodialysis N Engl J Med 360 14 2009 Apr 2 1395 1407
9. I. de Brito-Ashurst, M. Varagunam, M.J. Raftery, and M.M. Yaqoob Bicarbonate supplementation slows progression of CKD and improves nutritional status J Am Soc Nephrol 20 9 2009 Sep 2075 2084